Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 45 Pretax Margin % is 3.94% as of Mar. 2026, which is 63% above its 10-year median of 2.42. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.73 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, Pharmaniaga Bhd ranks worse than 58.12% on this metric.
The historical rank and industry rank for Pharmaniaga Bhd's Pretax Margin % or its related term are showing as below:
XKLS:7081'
s Pretax Margin % Range Over the Past 10 Years
Min: -17.54 Med: 2.42 Max: 5.75
Current: 1.87
XKLS:7081's Pretax Margin % is ranked worse than 58.12% of 117
companies
in the Medical Distribution industry
Industry Median: 2.31
vs XKLS:7081: 1.87
Pharmaniaga Bhd (XKLS:7081) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Pharmaniaga Bhd Pretax Margin % Related Terms
Pharmaniaga Bhd Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, CAH, COR: Pretax Margin % Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Pretax Margin % of 3.94% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pharmaniaga Bhd and its competitors. This is 63% above median its historical median of 2.42. According to the industry distribution chart, Pharmaniaga Bhd ranks #68 out of 117 companies in the Medical Distribution industry, placing it in the top 58.1%.
Is Pharmaniaga Bhd's Pretax Margin % too high?
Pharmaniaga Bhd's current Pretax Margin % of 3.94% is 63% above median its 10-year median of 2.42. The Medical Distribution industry median Pretax Margin % is 2.31. Pharmaniaga Bhd's value of 3.94% is 70.6% above this industry median. Based on the distribution chart, Pharmaniaga Bhd ranks #68 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Pretax Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #68 out of 117 companies for Pretax Margin %. This places Pharmaniaga Bhd in the lower half of its industry. The industry median Pretax Margin % is 2.31. Pharmaniaga Bhd's value of 3.94% is 70.6% above this benchmark. While the company's 10-year median is 2.42 vs. the industry median of 2.31, Pharmaniaga Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.31, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaniaga Bhd's current Pretax Margin % of 3.94% is 70.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Pretax Margin % is 3.94%, which is 63% above median its own 10-year median of 2.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.73, compared to a current price of RM1.18 — trading 61.6% above its estimated fair value. The current Pretax Margin % is 3.94%, which is 63% above median its 10-year median of 2.42 and 70.6% above the Medical Distribution industry median of 2.31. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Pretax Margin % is 3.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 61.6% above its estimated GF Value™ of RM0.73.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Pretax Margin %: 3.94% (63% above median its 10-year median of 2.42)
GF Value™: RM0.73 vs. price of RM1.18 (61.6% above fair value)
Industry Position: 70.6% above the Medical Distribution median (#68 of 117)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
